About Florentis Pharmaceuticals
Florentis Pharmaceuticals is a Healthcare company based in Pune (India) founded in 2011. It offers custom synthesis, process development, and analytical services for pharmaceutical research. It operates on a B2B and Fee For Service model in Healthcare and Chemicals & Materials sectors. The company has 7 employees. Its Indian entity Florentis Pharmaceuticals Private Limited reported revenue of ₹1.55 Cr. Florentis Pharmaceuticals offers products and services including Custom Synthesis, Asymmetric Synthesis, Process Development, and Analytical Services. Its focus areas include Health, Pharmaceuticals, Drug Development and API Synthesis. Similar companies include Sai Life Sciences, NFIL and Sapala Organics; 2 of its 3 listed similar companies have raised funding.
Company details
Florentis Pharmaceuticals is a contract research organization based in Pune, India, specializing in synthetic organic chemistry and medicinal chemistry. They develop cost-effective synthetic routes for drug intermediates and APIs, including asymmetric synthesis and analytical services. Their activities focus on empowering drug discovery through efficient, confidential projects, serving clients in the pharmaceutical industry with expertise in chiral synthesis and process optimization.
- Headquarters Pune, India
- Employees 7
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Website florentispharma.com
- Social LinkedIn X Facebook
- Legal Name Florentis Pharmaceuticals Private Limited
- Date of Incorporation 26 Sep, 2011
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹1.55 Cr
FY 2025 · -29% YoY
- Net Profit₹78,894
FY 2025 · 1% margin
- EBITDA₹9.7 Lakh
FY 2025 · 6% margin
- Employee Count7
Associated legal entities of Florentis Pharmaceuticals
Florentis Pharmaceuticals operates through Florentis Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Florentis Pharmaceuticals Private Limited CIN U24100PN2011PTC140877 | Active | 26 Sep 2011 | Pune, Maharashtra | ₹1.5 Cr | 7 | 3 | View details |
Products & Services of Florentis Pharmaceuticals
Florentis Pharmaceuticals offers a comprehensive portfolio of products and services, including Custom Synthesis, Asymmetric Synthesis, Process Development, and Analytical Services.
Develops synthetic routes for drug intermediates and APIs.
Provides chiral organic synthesis for pharmaceutical applications.
Optimizes cost-effective processes for drug production.
Offers purification and analysis of pharmaceutical compounds.
Board of directors of Florentis Pharmaceuticals Private Limited (Florentis Pharmaceuticals)
Florentis Pharmaceuticals Private Limited is the primary company behind Florentis Pharmaceuticals. The board of Florentis Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Shriram Parasram Kotkar, appointed in 2011. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shriram Parasram Kotkar DIN 03615825 | Director | 26 Sep 2011 | 15 yrs | Florentis Pharmaceuticals Private Limited |
| Laxman Hanmantrao Malge DIN 03615822 | Director | 26 Sep 2011 | 15 yrs | Florentis Pharmaceuticals Private Limited |
| Vijaykumar Gangadharrao Pawar DIN 06479666 | Director | 24 Jan 2013 | 13 yrs 9 mo | Florentis Pharmaceuticals Private Limited |
Financials of Florentis Pharmaceuticals
Figures of Florentis Pharmaceuticals Private Limited, the primary company behind Florentis Pharmaceuticals, for FY 2025. Revenue was ₹1.55 Cr (-29% year on year). Net profit was ₹78,894 (1% margin). EBITDA was ₹9.7 Lakh (6% margin). Revenue has grown at a compounded annual rate of -7% over three years and -4% over five years.
- ₹1.55 CrRevenue · FY 2025 · -29% YoY
- ₹78,894Net profit · 1% margin
- ₹9.7 LakhEBITDA · 6% margin
- ₹8.2 LakhPaid-up capital
- 7Employees (provident fund records)
- -7%Revenue CAGR, 3 years
- -4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Florentis Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Florentis Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Florentis Pharmaceuticals
Florentis Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Sai Life Sciences, NFIL and Sapala Organics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sailife.com | 1999 | Hyderabad, India | $112.18M | 2,948 | Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. | |
| nfil.in | 1967 | Mumbai, India | 1,476 | Fluorinated compounds are synthesized and manufactured customly for various industries. | ||
| sapalaorganics.com | 2005 | Hyderabad, India | $734,962 | 219 | Research organization specializing in custom synthesis of various organic compounds |
Detailed similar companies of Florentis Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Florentis Pharmaceuticals
Florentis Pharmaceuticals was founded in 2011.
Florentis Pharmaceuticals is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Florentis Pharmaceuticals has 7 employees.
The primary company behind Florentis Pharmaceuticals, Florentis Pharmaceuticals Private Limited, reported revenue of ₹1.55 Cr for FY 2025, down 29% year on year.
Florentis Pharmaceuticals is a contract research organization based in Pune, India, specializing in synthetic organic chemistry and medicinal chemistry. They develop cost-effective synthetic routes for drug intermediates and APIs, including asymmetric synthesis and analytical services. Their activities focus on empowering drug discovery through efficient, confidential projects, serving clients in the pharmaceutical industry with expertise in chiral synthesis and process optimization.
Florentis Pharmaceuticals's top competitors include Sai Life Sciences, NFIL and Sapala Organics.
Florentis Pharmaceuticals offers Custom Synthesis, Asymmetric Synthesis, Process Development, and Analytical Services.
Florentis Pharmaceuticals operates through Florentis Pharmaceuticals Private Limited.
The legal entities of Florentis Pharmaceuticals currently have 3 directors, including Vijaykumar Gangadharrao Pawar, Shriram Parasram Kotkar, Laxman Hanmantrao Malge.